Kanagawa, Japan

Kazuo Masuda

This inventor holds 1 USPTO granted patent. Top assignee: Toa Pharmaceutical Co., Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuo Masuda. Retrieved from https://idiyas.com/inventor/kazuo-masuda-8tjcblp9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuo Masuda: Innovator in Bifidobacterium Research

Introduction

Kazuo Masuda is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that promote the growth of beneficial bacteria.

Latest Patents

Masuda holds a patent for an azetidine derivative, specifically a bifidobacterium division-promoting composition. This innovative compound includes 3,3-dihydroxyazetidine and is designed to enhance the multiplication of bifidobacterium. The patent outlines not only the composition but also the process for producing this novel azetidine derivative.

Career Highlights

Kazuo Masuda is associated with Toa Pharmaceutical Co., Ltd., where he has been instrumental in advancing research in microbiology and pharmaceuticals. His work focuses on creating solutions that can improve gut health through the promotion of beneficial bacteria.

Collaborations

Masuda has collaborated with notable colleagues, including Takashi Masuda and Taketoshi Arai. These partnerships have contributed to the successful development of his innovative research.

Conclusion

Kazuo Masuda's work in developing azetidine derivatives showcases his commitment to advancing health through scientific innovation. His contributions to the field of biotechnology are significant and continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…